JOURNAL ARTICLE
Prevalence, demographics, and clinical correlates of antisocial personality disorder in Chinese methamphetamine patients.
Published In: American Journal on Addictions, 2023, v. 32, n. 1. P. 47 1 of 3
Database: Academic Search Ultimate 2 of 3
Authored By: Li, Yuqing; Tian, Yang; Fan, Fusheng; Chen, Jiajing; Fu, Fabing; Zhu, Rongrong; Wei, Dejun; Tang, Shanshan; Zhou, Huixia; Wang, Dongmei; Zhang, Xiangyang 3 of 3
Abstract
Background and Objectives: Antisocial personality disorder (ASPD) is very common among methamphetamine (MA) patients, but very few studies have been conducted in China. This study aimed to investigate the prevalence and clinical correlates of ASPD among Chinese MA patients. Methods: We recruited 627 MA patients and collected demographic and MA use data through one‐on‐one semi‐structured interviews. ASPD was measured by the Mini International Neuropsychiatric Interview (M.I.N.I.). The Desires for Drug Questionnaire (DDQ) and visual analog scale (VAS) were used to assess drug cravings. Results: The prevalence rate of ASPD among MA patients was 27.59% (173/627). Patients with ASPD had greater age at the first onset, duration of MA use, length of abstinence, VAS, DDQ desire and intention, negative reinforcement, and total DDQ scores than patients without ASPD. Stepwise binary logistic regression analysis revealed that age, age at the first onset, length of abstinence, and DDQ‐negative reinforcement were independently associated with ASPD in MA patients. Discussion and Conclusions: Our findings suggest that the prevalence of ASPD is high among Chinese MA patients. Furthermore, some demographic and clinical variables are associated with ASPD in MA patients. Scientific Significance: We focused our study on the clinical profile of ASPD and the reasons for its high prevalence in Chinese methamphetamine patients. We identified several demographic and clinical variables as correlates of the occurrence of ASPD in methamphetamine patients, which provides evidence for ASPD comorbidity in methamphetamine patients. [ABSTRACT FROM AUTHOR]
Additional Information
- Source:American Journal on Addictions. 2023/01, Vol. 32, Issue 1, p47
- Document Type:Article
- Subject Area:Health and Medicine
- Publication Date:2023
- ISSN:1055-0496
- DOI:10.1111/ajad.13361
- Accession Number:160964371
- Copyright Statement:Copyright of American Journal on Addictions is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Looking to go deeper into this topic? Look for more articles on EBSCOhost.